Flagship Presents AI Solutions at SITC

November 7, 2018 – Flagship Biosciences will present its artificial intelligence (AI) driven immunotherapy solutions at the SITC annual conference, November 9-10, 2018, in Washington DC.

Flagship will present a poster, “Using Artificial Intelligence to Predict Response to Immunotherapy,” (P90) at the Washington Convention Center, Hall E, on Friday, Nov. 9 and Saturday, Nov. 10. Kelsey Weigel, PhD, Flagship Scientist and poster author, will be available to discuss the research and Flagship’s solutions on Saturday, Nov. 10, 12:20 – 1:50 pm and 7:00 – 8:30 pm Eastern Time.